Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group

Research output: Contribution to journalReview articlepeer-review


  • Bo Shen
  • Marietta Iacucci (Contributor)
  • Global Interventional Inflammatory Bowel Disease Group

Colleges, School and Institutes

External organisations

  • Cleveland Clinic


Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.


Original languageEnglish
Pages (from-to)215-237
Number of pages23
JournalGastrointestinal Endoscopy
Issue number2
Early online date24 Oct 2018
Publication statusPublished - 1 Feb 2019


  • IBD, Endoscopy